Agenus DSO Ratio 2011-2026 | AGEN

Annual DSO Ratio Agenus

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.58	2.13	4.13	7.93	1.65	36.1	39.6	9.31	9.66	184	144	-	0.144	12.6	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
184	0.144	35

Quarterly DSO Ratio Agenus

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.88	1.89	1.44	-	1.68	2.37	42.9	-	4.32	4.9	8.28	-	55.7	44.2	4.93	-	4.19	15.3	13	3.38	7.12	3.92	52.6	43.1	74.6	94.6	9.84	13.3	6.69	5.38	57.8	12.4	30.8	24.6	21.1	186	233	157	162	117	131	140	118	26.1	27	13.7	29.4	0.28	0.15	0.14	22.8	46.2	58	80.4	1.88	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
233	0.14	43.5

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Ultragenyx Pharmaceutical RARE	75.9	$ 19.23	-3.85 %	$ 1.9 B	USA
RedHill Biopharma Ltd. RDHL	358	$ 0.8	0.89 %	$ 428 M	Israel
Dr. Reddy's Laboratories Limited RDY	120	$ 13.56	-1.56 %	$ 2.25 B	India
Regeneron Pharmaceuticals REGN	152	$ 742.02	-1.94 %	$ 77.6 B	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
REGENXBIO RGNX	53.1	$ 7.88	-4.6 %	$ 406 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Rigel Pharmaceuticals RIGL	57.9	$ 26.2	-0.64 %	$ 471 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Avidity Biosciences RNA	45.1	$ 13.09	-0.08 %	$ 1.8 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Rhythm Pharmaceuticals RYTM	42.9	$ 78.52	-4.13 %	$ 5.1 B	USA
Adaptive Biotechnologies Corporation ADPT	60.7	$ 12.57	-9.96 %	$ 1.91 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	47.1	$ 5.35	7.76 %	$ 383 M	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 321.71	-1.96 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA